Lukas Biomedical

Lukas Biomedical Quick Ratio

The Quick Ratio (Acid Test) of Lukas Biomedical (6814.TWO) as of Nov 3, 2026 is 0.37. In the previous year, Quick Ratio (Acid Test) was 1.06 — a change of -65.29% (lower).

Quick Ratio

0.37

YoY

-65.29%

Last updated:

Quick Ratio (Acid Test) of Lukas Biomedical is 2025 0.37 . Quick Ratio (Acid Test) of Lukas Biomedical was 2024 1.06 . It decreases by -65.29% lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lukas Biomedical Stock analysis

What does Lukas Biomedical do? Lukas Biomedical, Inc. generates revenue through the lease and sale of medical equipment, as well as the research, design, development, and manufacture of immune cell products. The company offers beauty cosmetics, skin care products, and daily necessities such as dental floss, chewing gum, chewing spray, and dry hair products. Its makeup series includes eye shadow gel, eye color palette, lip gloss, lipstick, and lip wax. The firm provides services like brand authorization, management consulting, property leasing, and medical equipment leasing under an experience charging model for care institutions and medical management. The company’s products target consumers in the beauty and healthcare sectors, with medical equipment leased to care institutions and medical management entities. Immune cell products are developed for medical applications, while beauty and daily necessity products cater to personal care markets. The firm’s service model combines brand authorization with property and equipment leasing to support operational experience in healthcare facilities. Lukas Biomedical’s revenue streams include direct sales of medical equipment, lease agreements for medical devices, and the sale of immune cell products, beauty cosmetics, and daily necessities. Care institutions and medical management companies are key clients for leasing services, while beauty product lines serve individual consumers and retail channels. The experience charging model integrates brand authorization and management consulting to enhance service offerings for healthcare providers. Lukas Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lukas Biomedical stock

Quick Ratio (Acid Test) of Lukas Biomedical is 0.37 in 2025.

Quick Ratio (Acid Test) of Lukas Biomedical changed from 1.06 to 0.37, representing a -65.29% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Lukas Biomedical since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Lukas Biomedical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Lukas Biomedical

All Key Metrics — Lukas Biomedical